{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:54:25Z","timestamp":1793836465216,"version":"4.6.1"},"reference-count":39,"publisher":"Frontiers Media SA","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":377,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transpl Int"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1111\/tri.12375","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T08:39:15Z","timestamp":1403685555000},"page":"956-965","source":"Crossref","is-referenced-by-count":39,"title":["CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality"],"prefix":"10.3389","volume":"27","author":[{"given":"Nolwenn","family":"Rabot","sequence":"first","affiliation":[{"name":"Department of Nephrology Transplantation; H\u00f4pital Bretonneau; Tours University Hospital; Tours France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"B\u00fcchler","sequence":"additional","affiliation":[{"name":"Department of Nephrology Transplantation; H\u00f4pital Bretonneau; Tours University Hospital; Tours France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Foucher","sequence":"additional","affiliation":[{"name":"SPHERE Laboratory (EA 4275); Nantes University Hospital; INSERM U1064; Labex Transplantex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Moreau","sequence":"additional","affiliation":[{"name":"Department of Pathology; Nantes University Hospital; Nantes Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Debiais","sequence":"additional","affiliation":[{"name":"Department of Pathology; H\u00f4pital La Mil\u00e9trie; Poitiers University Hospital; Poitiers Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Machet","sequence":"additional","affiliation":[{"name":"Department of Pathology; H\u00f4pital Bretonneau; Tours University Hospital; Tours France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Kessler","sequence":"additional","affiliation":[{"name":"Department of Nephrology; H\u00f4pitaux de Brabois; Nancy University Hospital; Vand\u0153uvre-l\u00e8s-Nancy France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Morelon","sequence":"additional","affiliation":[{"name":"Department of Nephrology and Transplantation; Hospices Civils de Lyon; Edouard Herriot Hospital; Lyon Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Thierry","sequence":"additional","affiliation":[{"name":"Department of Nephrology Transplantation; H\u00f4pital La Mil\u00e9trie; Poitiers University Hospital; Poitiers Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Legendre","sequence":"additional","affiliation":[{"name":"Department of Adult Kidney Transplantation; AP-HP Necker; Inserm U845; Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Rivalan","sequence":"additional","affiliation":[{"name":"Department of Nephrology; Pontchaillou Hospital; Rennes University Hospital; Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Organ Transplantation; CHU Rangueil; Toulouse France"},{"name":"INSERM U1043; IFR-BMT; CHU Purpan; Toulouse France"},{"name":"Universit\u00e9 Paul Sabatier; Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Dantal","sequence":"additional","affiliation":[{"name":"Institut de Transplantation Urologie et N\u00e9phrologie; ITUN; Nantes University Hospital; Nantes Cedex France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2014,8,20]]},"reference":[{"key":"10.1111\/tri.12375-BIB0001|tri12375-cit-0001","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.2012.43.2344","article-title":"Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score","volume":"31","author":"Caillard","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1111\/tri.12375-BIB0002|tri12375-cit-0002","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/ndt\/gfq231","article-title":"Post-transplant lymphoproliferative disorder in view of the new WHO classification: a more rational approach to a protean disease?","volume":"25","author":"Mucha","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12375-BIB0003|tri12375-cit-0003","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/TP.0b013e318269e64f","article-title":"The Seville Expert workshop for progress in posttransplant lymphoproliferative disorders","volume":"94","author":"Glotz","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/tri.12375-BIB0004|tri12375-cit-0004","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1600-6143.2011.03896.x","article-title":"Epidemiology of posttransplant lymphoproliferative disorders in adult kidney and kidney pancreas recipients: report of the French registry and analysis of subgroups of lymphomas","volume":"12","author":"Caillard","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12375-BIB0005|tri12375-cit-0005","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1155\/2002\/634318","article-title":"Epstein-barr virus infection in transplant recipients: summary of a workshop on surveillance, prevention and treatment","volume":"13","author":"Allen","year":"2002","journal-title":"Can J Infect Dis"},{"key":"10.1111\/tri.12375-BIB0006|tri12375-cit-0006","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/infdis\/152.5.876","article-title":"Epstein-Barr virus infection and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection","volume":"152","author":"Ho","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1111\/tri.12375-BIB0007|tri12375-cit-0007","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/cncr.28043","article-title":"Cumulative incidence of cancer after solid organ transplantation","volume":"119","author":"Hall","year":"2013","journal-title":"Cancer"},{"key":"10.1111\/tri.12375-BIB0008|tri12375-cit-0008","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1200\/JCO.1998.16.6.2052","article-title":"Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity","volume":"16","author":"Leblond","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1111\/tri.12375-BIB0009|tri12375-cit-0009","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00000478-200003000-00006","article-title":"Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?","volume":"24","author":"Nelson","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/tri.12375-BIB0010|tri12375-cit-0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/TP.0b013e3181761659","article-title":"Prospective study of sequential reduction in immunosuppression, interferon alpha-2B, and chemotherapy for posttransplantation lymphoproliferative disorder","volume":"86","author":"Swinnen","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/tri.12375-BIB0011|tri12375-cit-0011","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/tri.12375-BIB0012|tri12375-cit-0012","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1600-6143.2010.03387.x","article-title":"Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder","volume":"11","author":"Reshef","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12375-BIB0013|tri12375-cit-0013","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1600-6143.2005.01211.x","article-title":"Treatment of PTLD with Rituximab or chemotherapy","volume":"6","author":"Elstrom","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12375-BIB0014|tri12375-cit-0014","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1600-6143.2005.00776.x","article-title":"Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant tumor Registry experience","volume":"5","author":"Trofe","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12375-BIB0015|tri12375-cit-0015","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant Study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12375-BIB0016|tri12375-cit-0016","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1200\/JCO.2009.25.4961","article-title":"Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcome and prognostic factors in the modern era","volume":"28","author":"Evens","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/tri.12375-BIB0017|tri12375-cit-0017","first-page":"343","volume-title":"WHO Classification of Tumors of Haemotopoietic and Lymphoid Tissue","author":"Swerdlow","year":"2008"},{"key":"10.1111\/tri.12375-BIB0018|tri12375-cit-0018","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ajh.21911","article-title":"Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States","volume":"86","author":"Quinlan","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1111\/tri.12375-BIB0019|tri12375-cit-0019","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2141.2010.08160.x","article-title":"Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS guidelines","volume":"149","author":"Parker","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/tri.12375-BIB0020|tri12375-cit-0020","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1097\/01.TP.0000144333.19106.58","article-title":"Experience with 274 cardiac transplant recipients with posttransplantation lymphoproliferative disorder: a report from the Israel Penn International Transplant tumor registry","volume":"78","author":"Aull","year":"2004","journal-title":"Transplantation"},{"key":"10.1111\/tri.12375-BIB0021|tri12375-cit-0021","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1111\/j.1600-6143.2009.02772.x","article-title":"Treatment of PTLD with Rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression","volume":"9","author":"Trappe","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12375-BIB0022|tri12375-cit-0022","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ki.2013.253","article-title":"Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival","volume":"1","author":"Serre","year":"2014","journal-title":"Kidney Int"},{"key":"10.1111\/tri.12375-BIB0023|tri12375-cit-0023","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.transproceed.2007.03.052","article-title":"Posttransplantation lymphoproliferative disorders in renal transplant recipients: report of over 20\u00a0years of experience","volume":"39","author":"Saadat","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1111\/tri.12375-BIB0024|tri12375-cit-0024","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2000.18.21.3622","article-title":"Durable remissison after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: a report of 16 cases observed in a single center","volume":"18","author":"Mamzer-Bruneel","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/tri.12375-BIB0025|tri12375-cit-0025","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.TP.0000072015.08302.E9","article-title":"Long-term follow-up of kidney transplant patients with posttransplant lymphoproliferative disorder: duration of posttransplant lymphoproliferative disorder-induced operational graft tolerance, interleukin-18 course, and results of retransplantation","volume":"76","author":"Birkeland","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/tri.12375-BIB0026|tri12375-cit-0026","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1111\/j.1600-6143.2006.01543.x","article-title":"Retransplantation after post-transplant lymphoproliferative disorders: an OPTN\/UNOS database analysis","volume":"6","author":"Johnson","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12375-BIB0027|tri12375-cit-0027","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1111\/j.1600-6143.2004.00562.x","article-title":"Successful renal retransplantation after post-transplant lymphoproliferative disease","volume":"4","author":"Karras","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12375-BIB0028|tri12375-cit-0028","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/j.1600-6143.2004.00623.x","article-title":"Retransplantation after post-transplant lymphoproliferative diseases (PTLD): when is it safe?","volume":"4","author":"Hanto","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12375-BIB0029|tri12375-cit-0029","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.healun.2004.04.011","article-title":"Lung retransplantation after posttransplantation lymphoproliferative disorder (PTLD): a single-center experience and review of literature of PTLD in lung transplant recipients","volume":"24","author":"Raj","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/tri.12375-BIB0030|tri12375-cit-0030","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/01.tp.0000179639.98338.39","article-title":"Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression","volume":"80","author":"Caillard","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/tri.12375-BIB0031|tri12375-cit-0031","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.TP.0000165098.49658.F3","article-title":"Lymphoproliferative disease after renal transplantation in Australia and New Zeland","volume":"80","author":"Faull","year":"2005","journal-title":"Transplantation"},{"key":"10.1111\/tri.12375-BIB0032|tri12375-cit-0032","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMoa1204166","article-title":"Sirolimus and secondary skin-cancer prevention in kidney transplantation","volume":"367","author":"Euvrard","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/tri.12375-BIB0033|tri12375-cit-0033","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/j.1600-6143.2012.04004.x","article-title":"Randomized controlled trial of sirolimus for renal transplant recipients at high risk for nonmelanoma skin cancer","volume":"12","author":"Campbell","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1111\/tri.12375-BIB0034|tri12375-cit-0034","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1432-2277.2008.00655.x","article-title":"Inhibition of mTOR by sirolimus induces remission of post transplant lymphoproliferative disorders","volume":"21","author":"Boratynska","year":"2008","journal-title":"Transpl Int"},{"key":"10.1111\/tri.12375-BIB0035|tri12375-cit-0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ndt\/gfm088","article-title":"Post transplant lymphoproliferative disorder: the potential of proliferation signal inhibitors","volume":"22","author":"Pascual","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/tri.12375-BIB0036|tri12375-cit-0036","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","article-title":"Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses","volume":"27","author":"Majewski","year":"2003","journal-title":"Transplantation"},{"key":"10.1111\/tri.12375-BIB0037|tri12375-cit-0037","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.080068597","article-title":"The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo: a potential approach to prevention and treatment of posttransplant lymphoproliferative disorders","volume":"97","author":"Majewski","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/tri.12375-BIB0038|tri12375-cit-0038","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/TP.0b013e31823ae7db","article-title":"Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients","volume":"93","author":"Sampaio","year":"2012","journal-title":"Transplantation"},{"key":"10.1111\/tri.12375-BIB0039|tri12375-cit-0039","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/MOT.0b013e3283186ba9","article-title":"Epstein-Barr virus, rapamycin and host immune responses","volume":"13","author":"Krams","year":"2008","journal-title":"Curr Opin Organ Transplant"}],"container-title":["Transplant International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftri.12375","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tri.12375\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T18:41:28Z","timestamp":1641062488000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tri.12375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,20]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"URL":"https:\/\/doi.org\/10.1111\/tri.12375","relation":{},"ISSN":["0934-0874"],"issn-type":[{"value":"0934-0874","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8,20]]}}}